Eastwood Bio-Medical Canada Inc (EBM) - Total Liabilities

Latest as of January 2026: CA$1.90 Million CAD ≈ $1.38 Million USD

Based on the latest financial reports, Eastwood Bio-Medical Canada Inc (EBM) has total liabilities worth CA$1.90 Million CAD (≈ $1.38 Million USD) as of January 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Eastwood Bio-Medical Canada Inc - Total Liabilities Trend (2013–2025)

This chart illustrates how Eastwood Bio-Medical Canada Inc's total liabilities have evolved over time, based on quarterly financial data. See EBM current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Eastwood Bio-Medical Canada Inc Competitors by Total Liabilities

The table below lists competitors of Eastwood Bio-Medical Canada Inc ranked by their total liabilities.

Company Country Total Liabilities
Korea Computer Inc
KQ:054040
Korea ₩132.34 Billion
HCL Infosystems Limited
NSE:HCL-INSYS
India Rs7.25 Billion
InfoBeans Technologies Limited
NSE:INFOBEAN
India Rs739.00 Million
WooGene B&G Co. Ltd
KQ:018620
Korea ₩50.21 Billion
Mccoy Global Inc
TO:MCB
Canada CA$26.42 Million
Singular Health Group Ltd
AU:SHG
Australia AU$856.60K
Claranova SE
PA:CLA
France €96.30 Million
SOLUCIONES CUATROO.EO-04
F:5XW
Germany €27.83 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Eastwood Bio-Medical Canada Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Eastwood Bio-Medical Canada Inc.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.04 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.15 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 7.57 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Eastwood Bio-Medical Canada Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Eastwood Bio-Medical Canada Inc (2013–2025)

The table below shows the annual total liabilities of Eastwood Bio-Medical Canada Inc from 2013 to 2025.

Year Total Liabilities Change
2025-10-31 CA$1.85 Million
≈ $1.34 Million
+17.65%
2024-10-31 CA$1.57 Million
≈ $1.14 Million
+18.12%
2023-10-31 CA$1.33 Million
≈ $962.05K
+51.35%
2022-10-31 CA$878.73K
≈ $635.66K
+5.18%
2021-10-31 CA$835.44K
≈ $604.35K
+76.21%
2020-10-31 CA$474.10K
≈ $342.96K
+41.22%
2019-10-31 CA$335.73K
≈ $242.86K
-7.11%
2018-10-31 CA$361.41K
≈ $261.44K
+548.22%
2017-10-31 CA$55.76K
≈ $40.33K
+56.77%
2016-10-31 CA$35.56K
≈ $25.73K
-63.74%
2015-10-31 CA$98.08K
≈ $70.95K
+9.98%
2014-10-31 CA$89.19K
≈ $64.52K
-97.72%
2013-10-31 CA$3.92 Million
≈ $2.83 Million
--

About Eastwood Bio-Medical Canada Inc

V:EBM Canada Food Distribution
Market Cap
$45.84 Million
CA$63.38 Million CAD
Market Cap Rank
#22389 Global
#802 in Canada
Share Price
CA$0.92
Change (1 day)
-1.08%
52-Week Range
CA$0.30 - CA$1.10
All Time High
CA$8.48
About

Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. It also offers Eleotin A 700 for the treatment for spleen deficiency, lack of appeti… Read more